Dr. Douglas Scott Scherr, MD

Dr. Scherr practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Scherr's NPI, 1114014206, was assigned on October 9, 2006. Dr. Scherr graduated from George Washington University School of Medicine and Health Sciences in 1994. Dr. Scherr's New York license number on file is 204529.

Dr. Scherr's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Scherr's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Scherr to 2 more clinical labs, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scherr practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Scherr's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Scherr is board certified in urology by the American Board of Urology. Dr. Scherr has a license on file in New York.

Dmand AI lists bladder removal, enlarged prostate, kidney cysts, kidney removal surgery, kidney stone disease, prostate surgery, transurethral procedures and urinary endoscopy among the conditions Dr. Scherr treats.

CMS data shows 12,372 Medicare services from Dr. Scherr across 23 procedure codes in 2024, for 928 Medicare patients. Medicare paid $474,319 for them.

CMS counts 928 Medicare patients who saw Dr. Scherr in 2024. The largest group is 75 to 84, with 466 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Scherr's median patient age at 74, with 27% women.

In 2024, Dr. Scherr wrote 697 Medicare Part D claims for 415 patients. 98% of them were for generic drugs. CMS names the drug for 624 of them, across 6 drugs with 11 or more claims each, at $3,479 in total drug cost. In 2023, CMS named 916 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Scherr for performance year 2024, reported through an alternative payment model (APM). Dr. Scherr accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Scherr as offering telehealth. CMS counts 25 procedures of prostate resection by Dr. Scherr, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 280 papers to Dr. Scherr, published from 2006 to 2025. 2021 was the busiest year, with 19. The most frequent topics are Urinary Bladder Neoplasms, Carcinoma, Transitional Cell and Cystectomy. Dr. Scherr has published most often in J Urol. Dr. Scherr's most frequent co-authors are Yair Lotan, MD, Casey Ki Ng, MD and Eugene K. Cha, MD.

Dmand AI links Dr. Scherr to 7 clinical trials, 2 of them phase 1 studies. Conditions studied include Prostatic Neoplasms, Urinary Bladder Neoplasms and Prostatic Diseases. Weill Medical College of Cornell University sponsors the most, 3.

CMS Open Payments shows 54 general payments to Dr. Scherr from 13 drug and device companies from 2016 to 2025. Education make up the largest share, 54% of the total. Intuitive Surgical, Inc. paid the most, $7,473. It also lists 1 research payment totaling $352 in 2020.

Dmand AI lists 5 awards for Dr. Scherr, most recently America's Top Doctors in 2014.

Dr. Scherr graduated from George Washington University School of Medicine and Health Sciences in 1994.

Dr. Scherr is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.